{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:15Z","timestamp":1792784535884,"version":"4.5.0"},"reference-count":37,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2026J001528"],"award-info":[{"award-number":["2026J001528"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2025Y9198 ,2023Y9009"],"award-info":[{"award-number":["2025Y9198 ,2023Y9009"]}]},{"name":"High Innovation Plan","award":["202504841043"],"award-info":[{"award-number":["202504841043"]}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["82472012 and 82672596"],"award-info":[{"award-number":["82472012 and 82672596"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation","award":["7262222, L2612013"],"award-info":[{"award-number":["7262222, L2612013"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Trophoblast cell surface antigen 2 (TROP-2) is a transmembrane glycoprotein overexpressed across a range of epithelial malignancies, yet its clinical assessment still relies largely on invasive immunohistochemical analysis of biopsied tissues. In this study, we employed the PepMimic artificial intelligence platform to de novo design a TROP-2-targeting peptide, TR23, via binding interface mimicry, which was subsequently conjugated with DOTA and radiolabeled with 68Ga to yield the peptide-based PET probe [68Ga]Ga-DOTA-TR23. The tracer bound TROP-2 with nanomolar affinity (KD = 26.8 nM), showed selective cellular uptake in TROP-2-positive cells, and exhibited high radiochemical purity (&amp;gt;95%) with excellent stability in saline and serum. Micro-PET\/CT imaging in pancreatic (BxPC-3), prostate (PC3), and thyroid (BCPAP) xenograft models revealed rapid, specific tumor accumulation with high contrast and low background uptake, while competitive blocking studies with excess unlabeled TR23 substantially suppressed tumor uptake, confirming receptor-mediated specificity. Quantitative analysis further demonstrated strong positive correlations between SUVmax and TROP-2 expression levels verified by immunohistochemistry across all three tumor types. Collectively, these findings establish [68Ga]Ga-DOTA-TR23 as a promising peptide-based PET tracer for rapid, specific, and quantitative imaging of TROP-2-positive tumors, and highlight the PepMimic-enabled strategy as a versatile platform for peptide-based probe discovery, supporting the translational potential of this tracer as a pan-cancer diagnostic agent for precision molecular imaging.<\/jats:p>","DOI":"10.1021\/acs.bioconjchem.6c00394","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:01:51Z","timestamp":1791464511000},"page":"2043-2053","source":"Crossref","is-referenced-by-count":0,"title":["De Novo Design of a TROP-2-Targeting Peptide PET Tracer via AI-Guided Binding Interface Mimicry"],"prefix":"10.1021","volume":"37","author":[{"given":"Zefang","family":"Lin","sequence":"first","affiliation":[{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350005"]},{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350212"]},{"name":"Department of Nuclear Medicine Provincial Clinical Key Specialty of Fujian , ,","place":["Fuzhou, China, 350212"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Yang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Sciences , , ,","place":["Beijing, China, 100101"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Ma","sequence":"additional","affiliation":[{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350005"]},{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350212"]},{"name":"Department of Nuclear Medicine Provincial Clinical Key Specialty of Fujian , ,","place":["Fuzhou, China, 350212"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuting","family":"Lin","sequence":"additional","affiliation":[{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350005"]},{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350212"]},{"name":"Department of Nuclear Medicine Provincial Clinical Key Specialty of Fujian , ,","place":["Fuzhou, China, 350212"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shihezi University , , ,","place":["Shihezi, China, 832003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350005"]},{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350212"]},{"name":"Department of Nuclear Medicine Provincial Clinical Key Specialty of Fujian , ,","place":["Fuzhou, China, 350212"]},{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350005"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6178-3422","authenticated-orcid":true,"given":"Zihua","family":"Wang","sequence":"additional","affiliation":[{"name":"Fujian Medical University , , ,","place":["Fuzhou, China, 350005"]},{"name":"Xuanwu Hospital Capital Medical University , , ,","place":["Beijing, China, 100053"]},{"name":"Beijing Key Laboratory of Innovation and Translation of Central Nervous System Radiopharmaceuticals , ,","place":["Beijing, China, 100069"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"9","key":"2026102103085263600_cit1","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.7150\/thno.98178","article-title":"Trop2-targeted therapies in solid tumors: advances and future directions","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"2026102103085263600_cit2","doi-asserted-by":"publisher","first-page":"117863","DOI":"10.1016\/j.ejmech.2025.117863","article-title":"Evolution of TROP2: Biological insights and clinical applications","volume":"296","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"2026102103085263600_cit3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.breast.2022.10.015","article-title":"Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy","volume":"66","author":"Jeong","year":"2022","journal-title":"The Breast"},{"key":"2026102103085263600_cit4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-med-071322-065903","article-title":"Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors","volume":"75","author":"Nelson","year":"2024","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"2026102103085263600_cit5","doi-asserted-by":"publisher","first-page":"188902","DOI":"10.1016\/j.bbcan.2023.188902","article-title":"Targeting Trop-2 in cancer: Recent research progress and clinical application","volume":"1878","author":"Qiu","year":"2023","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"2026102103085263600_cit6","doi-asserted-by":"publisher","first-page":"108296","DOI":"10.1016\/j.pharmthera.2022.108296","article-title":"Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer","volume":"239","author":"Liu","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"2026102103085263600_cit7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40291-025-00814-5","article-title":"Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer","volume":"29","author":"Cursano","year":"2025","journal-title":"Mol. Diagn. Ther."},{"issue":"26","key":"2026102103085263600_cit8","doi-asserted-by":"publisher","first-page":"2301457","DOI":"10.1002\/adfm.202301457","article-title":"Enzyme-Encapsulated Protein Trap Engineered Metal\u2212Organic Framework-Derived Biomineral Probes for Non-Invasive Prostate Cancer Surveillance","volume":"33","author":"Yu","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"36","key":"2026102103085263600_cit9","doi-asserted-by":"publisher","first-page":"19783","DOI":"10.1021\/acs.analchem.5c03445","article-title":"Two-Dimensional Dissipative Paper-Based Immunoassay with Oxygen Vacancy-Enriched CeO2 Nanozymes for Portable Cancer Screening","volume":"97","author":"Yu","year":"2025","journal-title":"Anal. Chem."},{"issue":"7","key":"2026102103085263600_cit10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","article-title":"Advances in PET imaging of cancer","volume":"23","author":"Schwenck","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"2026102103085263600_cit11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41571-018-0123-y","article-title":"Integrating molecular nuclear imaging in clinical research to improve anticancer therapy","volume":"16","author":"de Vries","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"2026102103085263600_cit12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s44321-024-00059-5","article-title":"ImmunoPET imaging of Trop2 in patients with solid tumours","volume":"16","author":"Huang","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"2026102103085263600_cit13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.62347\/bkis3836","article-title":"TROP2-targeted molecular imaging: a promising tool for precision oncology","volume":"15","author":"Ye","year":"2025","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"2026102103085263600_cit14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2967\/jnumed.124.268564","article-title":"[(99m)Tc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study","volume":"66","author":"Sun","year":"2025","journal-title":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine"},{"issue":"13","key":"2026102103085263600_cit15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1158\/1078-0432.CCR-24-3098","article-title":"Pretargeted Trop-2 ImmunoPET for Rapid, Selective Detection of Pancreatic Tumors","volume":"31","author":"Pratt","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"2026102103085263600_cit16","doi-asserted-by":"publisher","first-page":"15118","DOI":"10.1021\/acs.jmedchem.4c00759","article-title":"Development of a Novel Peptide-Based PET Tracer [68Ga]Ga-DOTA-BP1 for BCMA Detection in Multiple Myeloma","volume":"67","author":"Song","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"2026102103085263600_cit17","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1039\/d2md00397j","article-title":"Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling","volume":"14","author":"Failla","year":"2023","journal-title":"RSC Med. Chem."},{"key":"2026102103085263600_cit18","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s11426-025-2856-2","article-title":"In silico design and preclinical evaluation of a novel Trop2-targeted peptide tracer for PET imaging of tumors","volume":"69","author":"Fang","year":"2025","journal-title":"Sci. China:Chem."},{"issue":"42","key":"2026102103085263600_cit19","doi-asserted-by":"publisher","first-page":"23598","DOI":"10.1021\/acs.analchem.5c05242","article-title":"Preclinical Evaluation of a Trop2-Targeted Peptide Probe for PET Imaging of Triple-Negative Breast Cancer","volume":"97","author":"Zha","year":"2025","journal-title":"Anal. Chem."},{"key":"2026102103085263600_cit20","doi-asserted-by":"publisher","first-page":"109204","DOI":"10.1016\/j.bioorg.2025.109204","article-title":"De novo discovery and preclinical evaluation of a novel peptide radiotracer for PET imaging of TROP-2 in non-small cell lung cancer","volume":"167","author":"Yu","year":"2025","journal-title":"Bioorg. Chem."},{"key":"2026102103085263600_cit21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41587-025-02761-2","article-title":"Target sequence-conditioned design of peptide binders using masked language modeling","volume":"44","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"2026102103085263600_cit22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41551-025-01507-4","article-title":"Peptide design through binding interface mimicry with PepMimic","volume":"10","author":"Kong","year":"2026","journal-title":"Nat. Biomed. Eng."},{"issue":"2","key":"2026102103085263600_cit23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1071\/CH21118","article-title":"Radiolabelled Peptides: Optimal Candidates for Theranostic Application in Oncology","volume":"75","author":"Hall","year":"2021","journal-title":"Aust. J. Chem."},{"issue":"7","key":"2026102103085263600_cit24","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.cell.2026.01.003","article-title":"Unified modeling of 3D molecular generation via atomic interactions with PocketXMol","volume":"189","author":"Peng","year":"2026","journal-title":"Cell"},{"issue":"2","key":"2026102103085263600_cit25","doi-asserted-by":"publisher","first-page":"2207330","DOI":"10.1002\/adma.202207330","article-title":"A Totipotent \u201cAll-In-One\u201d Peptide Sequentially Blocks Immune Checkpoint and Reverses the Immunosuppressive Tumor Microenvironment","volume":"35","author":"Zhang","year":"2023","journal-title":"Advanced Materials"},{"issue":"2","key":"2026102103085263600_cit26","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1021\/acs.analchem.5c07715","article-title":"Fe\u2212N3S Single-Atom Nanozyme with Asymmetric Coordination for Ultra-Low-Background Colorimetric Immunoassays","volume":"98","author":"Yu","year":"2026","journal-title":"Anal. Chem."},{"issue":"2","key":"2026102103085263600_cit27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00259-023-06454-3","article-title":"ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers","volume":"51","author":"Huang","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"2026102103085263600_cit28","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202414625","article-title":"D-Band-Center-Engineered Platinum-Based Nanozyme for Personalized Pharmacovigilance","volume":"64","author":"Yu","year":"2025","journal-title":"Angewandte Chemie International Edition"},{"issue":"12","key":"2026102103085263600_cit29","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1021\/acs.molpharmaceut.4c00848","article-title":"Trop2-Targeted Molecular Imaging in Solid Tumors: Current Advances and Future Outlook","volume":"21","author":"Liu","year":"2024","journal-title":"Mol. Pharmaceutics"},{"issue":"14","key":"2026102103085263600_cit30","doi-asserted-by":"publisher","first-page":"14843","DOI":"10.1021\/acs.jmedchem.5c01010","article-title":"Development and Preclinical Validation of a Novel 89Zr-Labeled BCMA-Targeting Antibody for ImmunoPET Imaging: Application in Multiple Myeloma Models and First-In-Nonhuman-Primates","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"12","key":"2026102103085263600_cit31","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1007\/s00259-025-07326-8","article-title":"[68Ga]Ga-NOTA-T4 ImmunoPET imaging for evaluating TROP2 expression in patients with solid tumors","volume":"52","author":"Jiang","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"2026102103085263600_cit32","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1021\/jacs.8b13178","article-title":"Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges","volume":"141","author":"Vinogradov","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"2026102103085263600_cit33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10989-023-10524-3","article-title":"Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics","volume":"29","author":"Barman","year":"2023","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"11","key":"2026102103085263600_cit34","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1021\/acs.molpharmaceut.5c01194","article-title":"Development of a 68Ga-Labeled Peptide Radiotracer for Noninvasive Imaging of PD-L1 Expression in Tumors","volume":"22","author":"Lin","year":"2025","journal-title":"Mol. Pharmaceutics"},{"issue":"41","key":"2026102103085263600_cit35","doi-asserted-by":"publisher","first-page":"6968","DOI":"10.2174\/0929867327666200320153837","article-title":"Radiolabeled Peptide Probes for Liver Cancer Imaging","volume":"27","author":"Cao","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"21","key":"2026102103085263600_cit36","doi-asserted-by":"publisher","first-page":"23389","DOI":"10.1021\/acs.jmedchem.5c02183","article-title":"64Cu-Labeled Stapled Peptide-Based Radiopharmaceuticals Targeting MDM2\/MDMX for Pan-p53 Tumors","volume":"68","author":"Tian","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026102103085263600_cit37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00259-022-05954-y","article-title":"Theranostic application of (64)Cu\/(177)Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models","volume":"50","author":"Li","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.bioconjchem.6c00394","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/37\/10\/2043\/68782377\/bc6c00394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/37\/10\/2043\/68782377\/bc6c00394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:12:03Z","timestamp":1792570323000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bcches\/article\/37\/10\/2043\/5446786\/De-Novo-Design-of-a-TROP-2-Targeting-Peptide-PET"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,8]]},"published-print":{"date-parts":[[2026,10,21]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.bioconjchem.6c00394","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}